V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004612 | 310002032 | null | 90.3 | Disease modification (D) | 2014-11-29 | 2014-12-01 | Bexarotene | N | null | 310020162 | MITOMYCIN INTRAVESICULAR |
| 310004613 | 310002032 | null | 54 | Not known (9) | 2015-08-21 | 2015-08-24 | Vemurafenib | N | N | 310020162 | GEMCITABINE + PACLITAXEL |
| 310004614 | 310002032 | 0 | 86.2 | Curative (C) | 2015-10-06 | 2015-10-08 | EOX | N | N | 310020162 | EOX |
| 310004615 | 310002032 | null | null | Neo-adjuvant (N) | 2014-11-27 | 2014-11-28 | Mitomycin Intravesical | N | N | 310020162 | LIPOSOMAL DOXORUBICIN |
| 310004616 | 310002032 | 1.67 | 66.4 | Palliative (P) | 2013-03-12 | 2013-03-23 | Paclitaxel (2 or 3 weekly) | N | null | 310020162 | CAPECITABINE + CISPLATIN |
| 310004617 | 310002033 | 1.71 | null | Palliative (P) | 2018-12-26 | 2018-07-18 | Hydroxycarbamide | Y | N | 310020172 | PACLITAXEL |
| 310004618 | 310002033 | 1.63 | 57.5 | Palliative (P) | 2018-01-05 | 2018-01-13 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310020172 | GEMCITABINE |
| 310004620 | 310002035 | 1.73 | 53.9 | Curative (C) | 2013-09-21 | 2013-09-23 | CHOEP - 14 days | N | N | 310020176 | CHOEP |
| 310004621 | 310002036 | 1 | null | Palliative (P) | 2016-10-07 | 2016-10-08 | IPILIMUMAB + NIVOLUMAB | Y | null | 310020177 | IPILIMUMAB + NIVOLUMAB |
| 310004622 | 310002036 | 1.77 | 105 | Curative (C) | 2013-12-04 | 2013-12-18 | NB HRNBL-1 MOD N7 CAV | 01 | N | 310020177 | NOT MATCHED |
| 310004623 | 310002037 | 0 | 105.2 | Disease modification (D) | 2013-08-12 | 2013-08-13 | Dacarbazine | N | N | 310020183 | RITUXIMAB |
| 310004624 | 310002038 | null | null | Curative (C) | 2014-05-12 | 2014-05-12 | Vemurafenib | N | null | 310020184 | ICON TRIAL |
| 310004626 | 310002040 | null | 80.5 | Not known (9) | 2015-09-12 | 2015-09-13 | ICON8 TRIAL | N | N | 310020186 | MITOMYCIN INTRAVESICULAR |
| 310004627 | 310002041 | 1.62 | 83 | Adjuvant (A) | 2014-04-10 | 2014-04-10 | Mitomycin Intravesical | N | N | 310020187 | DACARBAZINE |
| 310004628 | 310002042 | 1.56 | 70.2 | null | 2016-08-17 | 2016-08-23 | Imatinib 400mg | N | N | 310020191 | EOX |
| 310004629 | 310006867 | null | 72 | Palliative (P) | 2016-02-07 | 2016-02-21 | Imatinib 400mg | N | N | 310020192 | DACARBAZINE |
| 310004630 | 310002043 | 1.83 | 100.1 | Disease modification (D) | 2012-11-13 | 2013-10-27 | CHOEP - 21 days | N | N | 310020193 | CHOEP |
| 310004632 | 310002045 | 1.77 | 0 | Disease modification (D) | 2012-02-25 | 2016-11-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310020199 | EOX |
| 310004633 | 310002046 | null | 0 | Adjuvant (A) | 2014-12-27 | 2015-01-11 | Dacarbazine | 2 | N | 310020200 | BEXAROTENE |
| 310004634 | 310002047 | null | null | Palliative (P) | 2013-08-05 | 2013-08-08 | Hydroxycarbamide | N | N | 310020202 | OXALIPLATIN + MDG |
| 310004635 | 310002048 | 1.77 | null | Palliative (P) | 2013-07-19 | 2013-08-14 | EOX | 02 | N | 310020204 | CAPECITABINE + CISPLATIN |
| 310004636 | 310002049 | 1.76 | 110 | Palliative (P) | 2016-12-02 | 2016-12-09 | GEMCITABINE | N | N | 310020208 | GEMCITABINE |
| 310004637 | 310002049 | 1.96 | null | Palliative (P) | 2018-08-20 | 2018-08-20 | Dacarbazine | N | N | 310020208 | IMATINIB |
| 310004638 | 310002050 | 1.7 | 93 | Curative (C) | 2013-02-16 | 2013-02-18 | CHOEP | 02 | N | 310020211 | CHOEP |
| 310004640 | 310002052 | 1.81 | 87.4 | Palliative (P) | 2017-12-24 | 2018-01-18 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020215 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004641 | 310006869 | 1.53 | null | Palliative (P) | 2017-02-27 | 2017-03-14 | ECX | N | N | 310020217 | ECX |
| 310004642 | 310006869 | null | null | Disease modification (D) | 2012-07-27 | 2013-10-26 | GEM-P | null | null | 310020217 | RITUXIMAB |
| 310004643 | 310002053 | null | 66.4 | null | 2013-05-19 | 2013-05-19 | Rituximab (Maintenance) | N | N | 310020223 | DACARBAZINE |
| 310004644 | 310002053 | 1.68 | null | Palliative (P) | 2016-07-02 | 2016-07-16 | Hydroxycarbamide | Y | N | 310020223 | IMATINIB |
| 310004645 | 310009206 | 1.56 | 59.6 | Neo-adjuvant (N) | 2014-03-07 | 2014-03-07 | Bexarotene | 02 | N | 310020228 | CISPLATIN + ETOPOSIDE |
| 310004646 | 310009206 | null | null | Palliative (P) | 2014-12-12 | 2014-12-12 | IPILIMUMAB + NIVOLUMAB | null | null | 310020228 | IPILIMUMAB + NIVOLUMAB |
| 310004647 | 310002054 | 1.57 | 92 | Curative (C) | 2013-10-20 | 2013-11-18 | IMATINIB | N | N | 310020230 | MITOMYCIN INTRAVESICULAR |
| 310004648 | 310002054 | null | null | Neo-adjuvant (N) | 2015-08-14 | 2015-08-23 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020230 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004649 | 310002055 | 0 | 66.5 | Palliative (P) | 2017-11-22 | 2017-11-23 | IPILIMUMAB + NIVOLUMAB | null | N | 310020235 | IPILIMUMAB + NIVOLUMAB |
| 310004650 | 310002055 | null | 90.3 | Palliative (P) | 2016-12-05 | 2016-12-15 | CISPLATIN + FLUOROURACIL | 2 | N | 310020235 | IMATINIB |
| 310004651 | 310002055 | 1.66 | 105.7 | Palliative (P) | null | 2018-12-31 | ICON8 TRIAL | N | N | 310020235 | BCG |
| 310004652 | 310002055 | 1.75 | 76 | Palliative (P) | 2017-01-17 | 2017-02-16 | Capecitabine + Cisplatin | N | N | 310020235 | PACLITAXEL |
| 310004653 | 310002055 | 0 | 86.2 | Adjuvant (A) | 2013-10-09 | 2013-10-10 | Imatinib 400mg | 2 | Y | 310020235 | MITOMYCIN INTRAVESICULAR |
| 310004654 | 310002056 | 1.73 | 74.7 | Palliative (P) | null | 2018-09-02 | Vemurafenib | 2 | N | 310020248 | MITOMYCIN INTRAVESICULAR |
| 310004655 | 310002057 | 1.77 | 91.2 | null | 2013-09-24 | 2013-10-21 | Vemurafenib | 2 | N | 310020249 | CAPECITABINE + CISPLATIN |
| 310004656 | 310002058 | -1 | 62.4 | Palliative (P) | 2016-10-05 | 2016-10-19 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310020250 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004657 | 310002059 | 1.81 | null | Curative (C) | 2015-11-06 | 2015-11-06 | Bexarotene | null | null | 310020253 | DACARBAZINE |
| 310004658 | 310002060 | 1.87 | 101 | Neo-adjuvant (N) | 2013-11-28 | 2013-12-05 | Bexarotene | N | N | 310020264 | BCG |
| 310004659 | 310002060 | 0 | 103 | null | 2017-01-01 | 2017-01-01 | Hydroxycarbamide | 02 | N | 310020264 | CAPECITABINE + CISPLATIN |
| 310004660 | 310002061 | 1.68 | 70 | Palliative (P) | 2016-12-06 | 2016-12-09 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020268 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004661 | 310002062 | null | 52.8 | Disease modification (D) | 2013-07-23 | 2013-07-23 | null | N | N | 310020272 | NOT MATCHED |
| 310004663 | 310002064 | null | 62.3 | Palliative (P) | 2015-10-04 | 2015-10-05 | EOX | 2 | N | 310020279 | CISPLATIN + FLUOROURACIL |
| 310004664 | 310002064 | null | 76.2 | Curative (C) | 2013-09-20 | 2013-10-07 | Gemcitabine weekly | 02 | N | 310020279 | GEMCITABINE |
| 310004665 | 310002065 | null | 68 | Adjuvant (A) | 2015-02-27 | 2015-02-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310020281 | RITUXIMAB |
| 310004666 | 310002066 | 1.59 | 79 | Disease modification (D) | 2013-08-05 | 2013-08-05 | Vemurafenib | 02 | N | 310020286 | DACARBAZINE |